| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/03/2006 | US7115414 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders |
| 10/03/2006 | US7115404 UDP-galactose: β-D-galactose-R 4-α-D-galac-tosyltransferase, α4Gal-T1 |
| 10/03/2006 | US7115401 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
| 10/03/2006 | US7115400 Forming a template of the nucleic acid to be amplified, containing an oligonucleotide sequence Y at the 5' end and an oligonucleotide sequence Z at the 3' end, immobilizing the nucleic acid to a solid support at the 5' end; mixing with colony primers generating nucleic acid colonies |
| 10/03/2006 | US7115397 Methods and kits for purifying his-tagged proteins |
| 10/03/2006 | US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype |
| 10/03/2006 | US7115394 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115384 Device for the detection of preferential particles in sample |
| 10/03/2006 | US7115383 An amphetamine and a methamphetamine group linked by a linking group, a polyamino acid or a nonpolyamino acid label linked to a second linking group which is attached to first linking group at a equidistance from both drugs, and second linking group terminates in a functional group; antiboides; sample |
| 10/03/2006 | US7115382 contacting biological sample with an antibody having specific binding affinity for PAPP-A-, but not PAPP-A-/pro major basic protein complex, to detect PAPP-A- in the sample for screening for altered proliferation states in non-pregnant patients |
| 10/03/2006 | US7115381 Methods for treating cardiovascular disorders |
| 10/03/2006 | US7115380 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP) |
| 10/03/2006 | US7115379 A complex of an antibody or antigen-binding fragment and a polypeptide which chemoattracts peripheral blood monocytes or T-cells |
| 10/03/2006 | US7115378 Peptide biomarker and method of identification |
| 10/03/2006 | US7115377 Cells for use as tools in the detection of modulators of cellular activity |
| 10/03/2006 | US7115376 Fractionating polynucleotides by capillary electrophoresis in a sieving matrix |
| 10/03/2006 | US7115373 Diagnosing allergies via measuring expression of nuclear orphan receptor (NOR-1 receptor) gene; identifying modulators for treating atopic dermatitis |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115371 Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders |
| 10/03/2006 | US7115368 Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides |
| 10/03/2006 | US7115364 Arrays of nucleic acid probes on biological chips |
| 10/03/2006 | US7115363 Retrovirus capable of causing AIDS, means and methods for detecting it in vitro |
| 10/03/2006 | US7115361 Detection of CD8+ T cell responses to M. tuberculosis |
| 10/03/2006 | US7115360 Isolation and use of solid tumor stem cells |
| 10/03/2006 | US7115271 Protein D—an IgD-binding protein of Haemophilus influenzae |
| 10/03/2006 | US7115205 Method of simultaneous blood collection and separation using a continuous flow centrifuge having a separation channel |
| 10/03/2006 | US7115100 Tissue biopsy and processing device |
| 10/03/2006 | US7114541 Method for producing a 3-D micro flow cell and a 3-D micro flow cell |
| 10/03/2006 | US7114377 Methods and systems for ascertaining the roughness of a print media surface |
| 10/03/2006 | US7114376 Bale loader moisture sensing system |
| 10/03/2006 | US7114209 Method for cleaning a soiled article |
| 10/03/2006 | CA2161338C Large pore synthetic polymer membranes |
| 09/29/2006 | CA2738454A1 Ultraviolet radiation water treatment system employing a plurality of basins arranged in series |
| 09/28/2006 | WO2006102687A1 A liposome-based microarray and methods of use thereof |
| 09/28/2006 | WO2006102653A2 Methods and compositions for treating insulin resistance and obesity-induced diseases |
| 09/28/2006 | WO2006102612A2 Extracting reagent for hydrophobic analyte in whole blood |
| 09/28/2006 | WO2006102600A2 Materials and methods for identifying biointeractive nanostructures and/or nanoparticles |
| 09/28/2006 | WO2006102593A2 Device, system and method of detecting targets in a fluid sample |
| 09/28/2006 | WO2006102574A2 Detection of gdf-8 modulating agents |
| 09/28/2006 | WO2006102526A2 Identification of biomarkers by serum protein profiling |
| 09/28/2006 | WO2006102498A2 Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy |
| 09/28/2006 | WO2006102484A2 Symmetrically branched polymer conjugates and microarray assays |
| 09/28/2006 | WO2006102445A1 Method for profiling cells using conductance data |
| 09/28/2006 | WO2006102401A2 Normalization of gene expression data |
| 09/28/2006 | WO2006102352A2 Normalization of data using controls |
| 09/28/2006 | WO2006102348A1 Packaging container for test sensors |
| 09/28/2006 | WO2006102333A2 Ophthalmic use of agents which inhibit connective tissue growth factor binding and signalling via the trka/p75ntr receptor complex |
| 09/28/2006 | WO2006102312A2 Microarrayer with coaxial multiple punches |
| 09/28/2006 | WO2006102306A1 Packaging container for test sensors |
| 09/28/2006 | WO2006102272A2 Methods for treating tumors and cancerous tissues |
| 09/28/2006 | WO2006102200A2 Docetaxel immunoassay |
| 09/28/2006 | WO2006102111A2 Biomarker for sensitivity to mtor inhibitor therapy in kidney cancer |
| 09/28/2006 | WO2006102070A2 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/28/2006 | WO2006101963A1 Hydrogen sensor using enzyme-catalyzed reaction |
| 09/28/2006 | WO2006101925A2 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
| 09/28/2006 | WO2006101550A1 Miniaturized flow controller using closed loop regulation |
| 09/28/2006 | WO2006101503A2 Method for screening agents against human prostate disease |
| 09/28/2006 | WO2006101497A2 Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) |
| 09/28/2006 | WO2006101439A1 Screen |
| 09/28/2006 | WO2006101436A1 A peptide fingerprint from the de radation of elastin by hne |
| 09/28/2006 | WO2006101387A2 Method for interfering with blood coagulation by modulating cross-beta structures fibril formation |
| 09/28/2006 | WO2006101272A1 Target protein and target gene for drug discovery and screening method |
| 09/28/2006 | WO2006101229A1 Probe array and process for producing the same |
| 09/28/2006 | WO2006101137A1 Device for determining menopause stage |
| 09/28/2006 | WO2006101000A1 Anti-dermatan sulfate antibody and functional sulfated oligosaccharide |
| 09/28/2006 | WO2006100816A1 Substrate having self-assembly material arranged thereon and process for production of the same |
| 09/28/2006 | WO2006100797A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |
| 09/28/2006 | WO2006100685A2 Optical sensor device and image processing unit for measuring chemical concentrations, chemical saturations and biophysical parameters |
| 09/28/2006 | WO2006100673A2 Methods of individually optimizing treatment for an inflammation associated disease |
| 09/28/2006 | WO2006100586A1 Glycosidase-inhibiting iminosugars |
| 09/28/2006 | WO2006100582A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 09/28/2006 | WO2006100484A2 Deliver of molecules to a li id bila |
| 09/28/2006 | WO2006100480A1 A method for producing an aldehyde containing coating |
| 09/28/2006 | WO2006100477A1 Antigen detection |
| 09/28/2006 | WO2006100446A2 Method of diagnosing interstitial lung disease (ild) |
| 09/28/2006 | WO2006100443A2 Low volume assay apparatus and method |
| 09/28/2006 | WO2006100415A1 Determining the estimated date of embryo implantation and related dates |
| 09/28/2006 | WO2006100388A2 Cholesterol-mimetic pyrene probes |
| 09/28/2006 | WO2006100366A2 Method and device for the separation of biological particles contained in a liquid by means of vertical filtration |
| 09/28/2006 | WO2006100346A1 Method for determining prothrombin time |
| 09/28/2006 | WO2006100096A2 Methods to identify and characterize prolyl oligo-peptidases by using substrates and products thereof |
| 09/28/2006 | WO2006100063A2 Reagency and method for preventing time-dependent rna-expression in biological cells |
| 09/28/2006 | WO2006100033A1 Method for identifying cell-specific protein combination patterns |
| 09/28/2006 | WO2006099875A1 Antibodies against cd38 for treatment of multiple myeloma |
| 09/28/2006 | WO2006099747A1 Method for isolation of soluble polypeptides |
| 09/28/2006 | WO2006090428A3 Method for the separation and simultaneous direct determination of compounds belonging to at least one of the groups chosen among purines and pyrimidines, n- acetylated amino acids, mono and dicarboxylic acids, sulphurylated compounds, nitrosylated compounds, bifunctional aldehydes, vitamins of group b, and derivatives ther |
| 09/28/2006 | WO2006089185A3 Pharmacogenomic markers for prognosis of solid tumors |
| 09/28/2006 | WO2006074155A3 Device and method for separating molecules |
| 09/28/2006 | WO2006073738A3 Colorimetric sensors constructed of diacetylene materials |
| 09/28/2006 | WO2006073500A3 Lateral flow system and assay |
| 09/28/2006 | WO2006069403A3 Methods for producing soluble multi-membrane-spanning proteins |
| 09/28/2006 | WO2006068249A8 Method of obesity test and method of screening of preventive or therapeutic drug for obesity |
| 09/28/2006 | WO2006064197A3 Transgenic animals for assessing drug metabolism and toxicity |
| 09/28/2006 | WO2006060063A3 Method for determination of organic hydroperoxides |
| 09/28/2006 | WO2006052351A3 Biological microbeads for various flow cytometric applications |
| 09/28/2006 | WO2006041896A3 Detecting cell membrane protein endocytosis |
| 09/28/2006 | WO2006031330A3 METHOD OF REDUCING THE EFFECTS OF Aβ AND COMPOSITIONS THEREFORE |
| 09/28/2006 | WO2006015874A3 Method for diagnosing liver fibrosis |
| 09/28/2006 | WO2006015810B1 Fluorescence-based assays for the rapid quantitative analysis of biomolecules (proteins and nucleic acids) by accumulation on cells or beads |